The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells-Reference-Cited by-同舟云学术

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells

Published:2007 Issue:7 Volume:110 Page:1509-1519
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Deininger Michael W. N.,Cortes Jorge,Paquette Ron,Park Byung,Hochhaus Andreas,Baccarani Michele,Stone Richard,Fischer Thomas,Kantarjian Hagop,Niederwieser Dietger,Gambacorti-Passerini Carlo,So Charlene,Gathmann Insa,Goldman John M.,Smith Douglas,Druker Brian J.,Guilhot François

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. The development of imatinib as a therapeutic agent for chronic myeloid leukemia

2. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

3. Clonal Cytogenetic Abnormalities in Philadelphia Chromosome Negative Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib

4. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia

5. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-02

2. Acquired Ring Chromosomes in Tumors of Hematopoietic and Lymphoid Tissues;Human Ring Chromosomes;2024

3. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia;Leukemia;2023-10-04

4. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

5. High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population;Haematologica;2023-03-23